Dariohealth CORP. (DRIO) — 10-Q Filings
All 10-Q filings from Dariohealth CORP.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
DarioHealth Narrows Losses Amid Revenue Dip, Boosts Cash Reserves
— Nov 13, 2025 Risk: high
DarioHealth Corp. reported a total revenue of $5.007 million for the three months ended September 30, 2025, a decrease from $7.423 million in the same period of -
DarioHealth Q2 Loss Widens to $12.12M Despite 18.5% Revenue Jump
— Aug 12, 2025 Risk: high
DarioHealth Corp. reported a net loss of $12.12 million for the quarter ended June 30, 2025, a significant increase from the $10.47 million net loss in the prio -
DarioHealth Reports Q1 2025 Financials, Equity Issuances
— May 14, 2025 Risk: medium
DarioHealth Corp. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $42.7 million and total liabilities of $38.4 million -
DarioHealth Q3 2024: Assets $31.3M, Liabilities $27.2M
— Nov 7, 2024 Risk: medium
DarioHealth Corp. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $31.32 million and total liabilities of $27.19 m -
DarioHealth Reports Q2 2024 Results
— Aug 8, 2024 Risk: medium
DarioHealth Corp. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $30.02 million and total liabilities of $2.72 million -
DarioHealth Corp. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
DarioHealth Corp. (DRIO) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. DarioHealth Corp. filed a 10-Q report for the period ending March 31, 202
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX